|2.28||+0.33 / +16.92%|
As of 4:00pm ET
|2.40||+0.12 / +5.26%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +294.74% increase from the last price of 2.28.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.